Commodore Capital as of Dec. 31, 2022
Portfolio Holdings for Commodore Capital
Commodore Capital holds 35 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Xenon Pharmaceuticals (XENE) | 9.9 | $65M | 1.7M | 39.43 | |
| Miragen Therapeutics (VRDN) | 8.9 | $59M | 2.0M | 29.21 | |
| Cogent Biosciences (COGT) | 7.5 | $50M | 4.3M | 11.56 | |
| Bellus Health Com New | 6.6 | $44M | 5.3M | 8.22 | |
| Merus N V (MRUS) | 6.4 | $42M | 2.7M | 15.47 | |
| Cymabay Therapeutics | 5.4 | $36M | 5.7M | 6.27 | |
| Aclaris Therapeutics (ACRS) | 4.5 | $30M | 1.9M | 15.75 | |
| Akero Therapeutics (AKRO) | 4.4 | $29M | 537k | 54.80 | |
| Nuvalent Inc-a (NUVL) | 4.1 | $27M | 914k | 29.78 | |
| Celldex Therapeutics Com New (CLDX) | 3.3 | $22M | 496k | 44.57 | |
| Immunovant (IMVT) | 3.1 | $20M | 1.2M | 17.75 | |
| Arrowhead Pharmaceuticals (ARWR) | 2.8 | $19M | 462k | 40.56 | |
| Celcuity (CELC) | 2.8 | $19M | 1.3M | 14.01 | |
| Arcellx Common Stock (ACLX) | 2.8 | $18M | 591k | 30.98 | |
| Syndax Pharmaceuticals (SNDX) | 2.6 | $18M | 688k | 25.45 | |
| Day One Biopharmaceuticals I (DAWN) | 2.4 | $16M | 740k | 21.52 | |
| Prometheus Biosciences | 2.1 | $14M | 127k | 110.00 | |
| Allakos | 2.1 | $14M | 1.6M | 8.42 | |
| Kura Oncology (KURA) | 2.1 | $14M | 1.1M | 12.41 | |
| 4d Molecular Therapeutics In (FDMT) | 2.0 | $13M | 598k | 22.21 | |
| Avidity Biosciences Ord (RNA) | 2.0 | $13M | 591k | 22.19 | |
| Enanta Pharmaceuticals (ENTA) | 1.6 | $10M | 224k | 46.52 | |
| Imara | 1.5 | $10M | 2.5M | 4.09 | |
| Alpine Immune Sciences | 1.5 | $9.7M | 1.3M | 7.35 | |
| 89bio (ETNB) | 1.5 | $9.7M | 758k | 12.73 | |
| Cabaletta Bio (CABA) | 1.4 | $9.3M | 1.0M | 9.25 | |
| Vaxcyte (PCVX) | 1.3 | $8.3M | 174k | 47.95 | |
| Karyopharm Therapeutics | 1.0 | $6.6M | 1.9M | 3.40 | |
| Third Harmonic Bio (THRD) | 0.6 | $4.3M | 993k | 4.30 | |
| Larimar Therapeutics (LRMR) | 0.5 | $3.1M | 750k | 4.13 | |
| Acumen Pharmaceuticals (ABOS) | 0.4 | $2.7M | 498k | 5.40 | |
| Immunic (IMUX) | 0.4 | $2.5M | 1.8M | 1.40 | |
| Rezolute Com New (RZLT) | 0.4 | $2.5M | 1.2M | 2.07 | |
| Kalvista Pharmaceuticals (KALV) | 0.3 | $2.1M | 313k | 6.76 | |
| Dbv Technologies S A Sponsored Adr | 0.0 | $142k | 93k | 1.53 |
